"Recurrence within 6 months of platinum therapy": an adequate definition of "platinum-refractory" ovarian cancer?

Suppr

超能文献

作者信息

Markman M

出版信息

Gynecol Oncol. 1998 May;69(2):91-2. doi: 10.1006/gyno.1998.4997.

DOI:10.1006/gyno.1998.4997

PMID:9600812

Abstract

摘要

相似文献

"Recurrence within 6 months of platinum therapy": an adequate definition of "platinum-refractory" ovarian cancer?

Gynecol Oncol. 1998 May;69(2):91-2. doi: 10.1006/gyno.1998.4997.

Second-line therapy for potentially platinum-sensitive recurrent ovarian cancer: what is optimal treatment?铂类药物敏感的复发性卵巢癌二线治疗：最佳治疗方案是什么？

Gynecol Oncol. 2001 Apr;81(1):1-2. doi: 10.1006/gyno.2001.6162.

Continued chemosensitivity to cisplatin/carboplatin in ovarian carcinoma despite treatment with multiple prior platinum-based regimens.尽管之前接受过多种铂类方案治疗，但卵巢癌对顺铂/卡铂仍持续存在化疗敏感性。

Gynecol Oncol. 1997 Jun;65(3):434-6. doi: 10.1006/gyno.1997.4708.

Advanced ovarian cancer: a clinical update on first-line treatment, recurrent disease, and new agents.晚期卵巢癌：一线治疗、复发性疾病及新型药物的临床进展

J Natl Compr Canc Netw. 2004 Sep;2 Suppl 2:S60-73.

Chemotherapy for ovarian cancer: an evidence-based approach.卵巢癌的化疗：循证医学方法

Minerva Ginecol. 2004 Dec;56(6):539-45.

Role of pegylated liposomal doxorubicin (Caelyx) in the treatment of relapsing ovarian cancer.聚乙二醇化脂质体阿霉素（楷莱）在复发性卵巢癌治疗中的作用。

Anticancer Drugs. 2007 Jun;18(5):611-7. doi: 10.1097/CAD.0b013e32802623fc.

Cytotoxic effect of hyperthermia and chemotherapy with platinum salt on ovarian cancer cells: results of an in vitro study.热疗与铂盐化疗对卵巢癌细胞的细胞毒性作用：一项体外研究的结果

Eur Surg Res. 2011;46(3):139-47. doi: 10.1159/000324395. Epub 2011 Mar 4.

Lack of efficacy of 24-h infusional topotecan in platinum-refractory ovarian cancer: A Gynecologic Oncology Group trial.24小时持续输注拓扑替康治疗铂类难治性卵巢癌无效：一项妇科肿瘤学组试验

Gynecol Oncol. 1999 Dec;75(3):444-6. doi: 10.1006/gyno.1999.5640.

Medical therapy of advanced malignant epithelial tumours of the ovary.晚期卵巢恶性上皮性肿瘤的医学治疗

Forum (Genova). 2000 Oct-Dec;10(4):323-32.

[Pharmacotherapy in ovarian carcinoma].[卵巢癌的药物治疗]

MMW Fortschr Med. 2005 Oct 27;147(43):34-6.

引用本文的文献

Predictors of morbidity and mortality in patients submitted to cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy for ovarian carcinomatosis: a multicenter study.接受减瘤手术联合腹腔热灌注化疗治疗卵巢癌转移患者的发病和死亡预测因素：一项多中心研究

Pleura Peritoneum. 2020 Dec 4;6(1):21-30. doi: 10.1515/pp-2020-0139. eCollection 2021 Mar.

Treatment options in recurrent ovarian cancer: latest evidence and clinical potential.复发性卵巢癌的治疗选择：最新证据和临床潜力。

Ther Adv Med Oncol. 2014 Sep;6(5):229-39. doi: 10.1177/1758834014544121.

Epithelial ovarian cancer relapsing as isolated lymph node disease: natural history and clinical outcome.上皮性卵巢癌复发为孤立性淋巴结疾病：自然病史和临床结局。

BMC Cancer. 2008 Dec 12;8:367. doi: 10.1186/1471-2407-8-367.

Usefulness of third-line chemotherapy for women with recurrent ovarian, fallopian tube, and primary peritoneal cancer who receive platinum/taxane regimens as first-line therapy.对于接受铂类/紫杉烷方案作为一线治疗的复发性卵巢癌、输卵管癌和原发性腹膜癌女性患者，三线化疗的有效性。

J Cancer Res Clin Oncol. 2009 Apr;135(4):551-7. doi: 10.1007/s00432-008-0488-x. Epub 2008 Oct 1.

Outcome of ATP-based tumor chemosensitivity assay directed chemotherapy in heavily pre-treated recurrent ovarian carcinoma.基于ATP的肿瘤化疗药敏试验指导的化疗在多次预处理的复发性卵巢癌中的疗效

BMC Cancer. 2003 Jul 3;3:19. doi: 10.1186/1471-2407-3-19.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验